Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5867 posts found.

online_version

New CMO hops onto Bicycle Therapeutics

September 26, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Bicycle Therapeutics, GSK, Pfizer, biotech, drugs, pharma, pharmaceutical

Bicycle Therapeutics has moved to appoint industry veteran, Maria Koehler, to the position of Chief Medical Officer at the company. …
Appointment
tessa_hilado-web-aug2017-allergan

Allergan’s Executive VP and Chief Financial Officer steps down

September 26, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, appointment

Allergan has announced that its Executive Vice President and Chief Financial Officer Tessa Hilado intends to step down from her …
Appointment

FDA pointedly rejects Intellipharma’s opioid painkiller

September 26, 2017 Manufacturing and Production, Sales and Marketing FDA, Intellipharma, biotech, drugs, pharma, pharmaceutical

The FDA has been very public in its stance that it will look to gain the upper hand in bringing …
News
shutterstock_95714119

Cancer trials underrepresent minorities and elderly, Mayo Clinic says

September 26, 2017 Manufacturing and Production, Research and Development clinical trials, pharma, pharmaceutical

New research conducted by the Mayo Clinic in Minnesota has found participant groups for clinical trials in cancer underrepresent ethnic …
News
image_credit_interpol

Pangea X: the largest coordinated operation against counterfeit drugs

September 26, 2017 Manufacturing and Production, Sales and Marketing Europol, FDA, biotech, drugs, interpol, pharma, pharmaceutical

Operation Pangea X represents an anniversary, of sorts – as it stands as the 10th year of operations by Interpol …
News
pharmafocus_october__cover_2017

The October 2017 issue of Pharmafocus is now live!

September 26, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, EMA, Pharmafocus

The October edition of Pharmafocus is now live! You can read it here.
News

Pfizer sets up its own biotech to develop rejected drugs

September 26, 2017 Manufacturing and Production, Sales and Marketing Pfizer, SpringWorks Therapeutics, biotech, drugs, pharma, pharmaceutical

Pfizer has moved to set up an entirely independent company to develop four of its own clinical-stage drug candidates. The …
News
shutterstock_57369385

Refining the system: Improving patients’ access to medicine

September 25, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NCIE, drug access, eams, market access, pharma, pharmaceuticals

The MHRA and NICE have been slowly improving the ways that the UK’s patients access medicines, but now Brexit threatens …
Feature
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

September 22, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

It’s been a great week for drug research and access, with the first-ever FDA approval of a biosimilar in cancer …
News
acute_leukemia-all

Roche and AbbVie’s leukaemia combo smashes Phase 3 endpoint

September 19, 2017 Manufacturing and Production, Research and Development AbbVie, Rituxan, Roche, Venclexta, Venclyxto, leukaemia, pharma, pharmaceutical

Venclexta/Venclyxto (venetoclax), Roche and AbbVie’s oral B-cell lymphoma-2 (BCL-2) inhibitor, successfully met its primary endpoint in Phase 3 trials, providing …
News
janssen_latest_logo_on_sign_closer

Janssen reveals positive CHMP opinion, long-term data for psoriasis drug guselkumab

September 19, 2017 Manufacturing and Production, Research and Development, Sales and Marketing EMA< CHMP, Janssen, guselkumab, pharma, pharmaceuticals

Janssen has announced that its psoriasis drug guselkumab has been awarded a positive opinion by the EMA’s Committee for Medicinal …
News
roche__tree

FDA locks down combo immunotherapy trials, Roche added to hold

September 19, 2017 Manufacturing and Production, Sales and Marketing Roche, biotech, drugs, immunotherapy, pharma, pharmaceutical, tecentriq

The FDA has moved to ensure that all immunotherapy trials studying PD-1/L1 agents, alongside immunomodulatory medicines in certain blood cancers …
News
teva_copy

Teva completes sale of women’s health for $1.38 billion

September 19, 2017 Manufacturing and Production, Sales and Marketing Teva, biotech, drugs, pharma, pharmaceutical, women's health

Teva announced last week that it had reached an agreement to sell Paragard, an intrauterine copper contraceptive, to CooperSurgical for …
News
diabetes-776999_960_720

Swine flu pandemic linked to increased incidence of diabetes

September 19, 2017 Manufacturing and Production, Research and Development biotech, diabetes type 1, drugs, influenza, pharma, pharmaceutical, swine flu

The swine flu pandemic that swept the world in 2009 may have had unforeseen consequences in some populations, after researchers …
News
scholar_rock_heather_faulds_headshot_bizwire

Scholar Rock prise Regulatory Affairs director away from Biogen

September 18, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Scholar Rock, biotech, drugs, pharma, pharmaceutical

Scholar Rock has announced that it has moved to appoint Heather Faulds as Vice President of Regulatory Affairs. Faulds joins …
Appointment
The Gateway to Local Adoption Series

Latest content

FDA signals support for development of psychedelic therapies in mental healthmental health

April 28, 2026

New web series explores path from ophthalmic research to patient access

April 28, 2026

EMA backs plozasiran for rare lipid disorder with high pancreatitis risk

April 27, 2026

Study explores speech as marker in rare neurodegenerative disease

April 27, 2026

Ofichem brings all brands under single trading name

April 23, 2026